Yaron Barac to Neoadjuvant Therapy
This is a "connection" page, showing publications Yaron Barac has written about Neoadjuvant Therapy.
Connection Strength
0.036
-
Aravot D, Barac YD, Krutzwald-Josefson E, Allen AM, Flex D, Peled N, Kramer MR, Peysakhovich Y, Saute M. Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity. J Cardiothorac Surg. 2019 Jan 09; 14(1):7.
Score: 0.036